|
ZNF410 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.269800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.157600E-03 |
| Normal-vs-Stage2 |
4.509800E-02 |
| Normal-vs-Stage3 |
6.609700E-02 |
| Normal-vs-Stage4 |
5.052200E-01 |
| Stage1-vs-Stage2 |
9.986600E-01 |
| Stage1-vs-Stage3 |
7.244600E-01 |
| Stage1-vs-Stage4 |
3.501600E-01 |
| Stage2-vs-Stage3 |
7.906000E-01 |
| Stage2-vs-Stage4 |
4.419000E-01 |
| Stage3-vs-Stage4 |
5.576000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.669700E-02 |
| Normal-vs-AfricanAmerican |
7.825800E-02 |
| Normal-vs-Asian |
4.294400E-01 |
| Caucasian-vs-AfricanAmerican |
7.792000E-01 |
| Caucasian-vs-Asian |
8.722600E-01 |
| AfricanAmerican-vs-Asian |
9.514600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.689500E-02 |
| Normal-vs-Female |
1.033430E-01 |
| Male-vs-Female |
7.008600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.170000E-02 |
| Normal-vs-Extreme_Weight |
1.552490E-02 |
| Normal-vs-Obese |
1.345420E-01 |
| Normal-vs-Extreme_Obese |
4.481800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.180000E-01 |
| Normal_Weight-vs-Obese |
4.373200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.837600E-01 |
| Extreme_Weight-vs-Obese |
2.945200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.766400E-01 |
| Obese-vs-Extreme_Obese |
2.376200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.590600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.298390E-01 |
| Normal-vs-Age(61-80Yrs) |
1.044430E-02 |
| Normal-vs-Age(81-100Yrs) |
2.540600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.761200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.068100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.498100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.069770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.329730E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.498400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.185800E-01 |
| Normal-VS-Type2 PRCC |
7.94700000000814E-05 |
| Normal-VS-KIRP CIMP |
8.179400E-01 |
| Normal-VS-Unclassified PRCC |
1.830400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.90519999998529E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.011800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.019800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.679400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.301800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.598300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.555120E-03 |
| Normal-vs-N1 |
8.493000E-01 |
| Normal-vs-N2 |
4.558000E-03 |
| N0-vs-N1 |
1.091970E-02 |
| N0-vs-N2 |
7.597800E-02 |
| N1-vs-N2 |
1.836300E-02 |
|
|
